XML 106 R92.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Narrative) (Detail 1) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Nov. 02, 2016
Dec. 21, 2016
Jun. 30, 2018
Rising Health | Board of Directors | Casper Pharma, LLC      
Related Party Transaction [Line Items]      
Purchased inventory from related party     $ 290
Development Agreement I | Cronus Research Labs Private Limited      
Related Party Transaction [Line Items]      
Amount of cost incurred   $ 3,500  
Two amended and restated joint development agreements, description Under the terms of Development Agreement I, Cronus has agreed to pay the first $3,500 of the development costs incurred after December 21, 2016, and 50% of any development costs incurred above that threshold in exchange for obtaining reimbursement for its costs funded out of the profits earned, if any, from the pipeline products that are commercially launched, and a specified portion of the profits from those products thereafter.    
Percentage of development costs incurred above threshold   50.00%  
Development Agreement II | Cronus Research Labs Private Limited      
Related Party Transaction [Line Items]      
Amount of cost incurred $ 1,445    
Two amended and restated joint development agreements, description Under the terms of Development Agreement II, Cronus has agreed to pay the development costs for the products covered thereby in exchange for obtaining reimbursement for its costs funded out of the profits earned, if any, from such products that are commercially launched (subject to a $1,445 maximum), and a specified portion of the profits from those products thereafter.